Clinical Trial: Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: An Open-label, Phase II Study of KPS-0373 in Patients With SCD
Brief Summary: To evaluate the efficacy, safety and pharmacokinetics profile of KPS-0373 in patients with SCD
Detailed Summary:
Sponsor: Kissei Pharmaceutical Co., Ltd.
Current Primary Outcome: Scale for the assessment and rating of ataxia (SARA), ADL(Flow-FIM), Patient Improvement Impression [ Time Frame: 12 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Kissei Pharmaceutical Co., Ltd.
Dates:
Date Received: March 16, 2009
Date Started:
Date Completion:
Last Updated: February 1, 2010
Last Verified: February 2010